Squamous Non-Small Cell Lung Cancer (sqNSCLC) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025
Squamous Non-Small Cell Lung Cancer (sqNSCLC) Emerging Therapy and TPP Insights Thelansis’s “Squamous Non-Small Cell Lung Cancer (sqNSCLC) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Squamous Non-Small Cell Lung Cancer (sqNSCLC) Overview Squamous Non-Small Cell Lung Cancer (sqNSCLC) is a subtype of non-small cell lung cancer, which is one of the two main categories of lung cancer. This particular form originates in the squamous cells, which are flat, thin cells that line the inside of the airways in the lungs. It is often associated with a history of smoking and tends to develop in the central part of the lungs, near the main airways or bronchi. The disease is characterized by its aggressive nature and its tendency to cause...